abstract |
The present application for a first certificate of addition relates in particular, by means of new examples, to the general formula of the main patent. It relates in particular to the product corresponding to the following formula: - 11béta- [4- [2- (1-pyrrolidinyl) ethoxy] phenyl] estra-1,3,5- (10) -triene-3,17béta-diol as well as its application as a medicine. |